ESC Premium Access

SGLT2 inhibitors and alteration of substrate metabolism.

Congress Presentation

About the speaker

Professor Ele Ferrannini

CNR – National Research Council, Pisa (Italy)
1 presentation
0 follower

3 more presentations in this session

Epigenetic signatures and cardiovascular risk in diabetes.

Speaker: Professor F. Cosentino (Stockholm, SE)


Use of incretin-based therapies.

Speaker: Professor L. Ryden (Stockholm, SE)


Mechanisms of cardiovascular impact of SGLT2 inhibitors.

Speaker: Professor B. Staels (Lille Cedex, FR)


Access the full session

How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?

Speakers: Professor E. Ferrannini, Professor F. Cosentino, Professor L. Ryden, Professor B. Staels

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb